Robert Kim - Mar 24, 2023 Form 3 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role: Chief Medical Officer
Signature: /s/ August J. Moretti, Attorney-in-Fact for Robert Kim
Stock symbol: FDMT
Transactions as of: Mar 24, 2023
Transactions value $: $0
Form type: 3
Date filed: 4/5/2023, 09:28 PM
Next filing: Dec 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	FDMT	Stock Options (Right to Buy)							Mar 24, 2023	Common Stock	150K	$18.66	Direct	F1
holding	FDMT	Stock Options (Right to Buy)							Mar 24, 2023	Common Stock	70K	$15.78	Direct	F2
holding	FDMT	Stock Options (Right to Buy)							Mar 24, 2023	Common Stock	60K	$8.04	Direct	F3
holding	FDMT	Stock Options (Right to Buy)							Mar 24, 2023	Common Stock	40K	$20.24	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to the option vest on the first anniversary measured from October 7, 2020 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest and become exerciseable in equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.
F2	The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.
F3	The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.
F4	The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 10, 2023 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.